From: Interatrial block in prediction of all-cause mortality after first-ever ischemic stroke
Variable | All patients n = 235 | No IAB n = 138 | Partial IAB n = 56 | Advanced IAB n = 41 | P value | Intermediate risk patients n = 47 | High-risk patients n = 188 | P value | Patients without AF n = 186 |
---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 2–3-4 | 5 | 6 | 5–6 | 7 | |
Age, years, median (IQR) | 74 (65–81) | 71 (61–80) | 76 (69–82) | 79 (74–86) | 0.001 | 74 (57–80) | 74 (67–81) | 0.229 | 74 (62–80) |
Female gender, n (%) | 95 (40) | 52 (38) | 27 (48) | 16 (39) | 0.391 | 21 (45) | 74 (39) | 0.511 | 75 (40) |
Diabetes, n (%) | 38 (16) | 28 (17) | 7 (13) | 6 (15) | 0.603 | 0 | 38 (20) | < 0.001 | 27 (15) |
Vascular diseases, n (%) | 101 (43) | 54 (39) | 29 (52) | 18 (44) | 0.270 | 0 | 101 (54) | < 0.001 | 80 (43) |
Hypertension, n (%) | 139 (59) | 79 (57) | 38 (68) | 22 (53) | 0.290 | 0 | 139 (74) | < 0.001 | 107 (58) |
Cardiac failure, n (%) | 14 (6) | 9 (7) | 3 (5) | 2 (5) | 0.905 | 0 | 14 (7) | 0.341 | 7 (4) |
History of non-permanent AF before stroke onset, n (%) | 49 (21) | 27 (20) | 15 (27) | 7 (17) | 0.430 | 0 | 49 (26) | < 0.001 | NA |
NIHS scale, median (IQR) | 3 (2–6) | 3 (2–6) | 4 (2–11) | 4 (2–8) | 0.161 | 3 (1–5) | 3 (2–7) | 0.173 | 3 (2–6) |
Oral anticoagulants, n (%) | 43 (18) | 26 (19) | 14 (25) | 3 (7) | 0.098 | 3 (6) | 40 (21) | 0.019 | 22 (12) |
Advanced IAB, n (%) | 41 (17) | 0 | 0 | NA | NA | 11 (23) | 30 (16) | 0.281 | 34 (18) |
Died during follow-up, n (%) | 126 (54) | 64 (46) | 32 (57) | 30 (73) | 0.009 | 22 (47) | 104 (55) | 0.329 | 96 (52) |